Kyowa Kirin North America

Kyowa Kirin is a global specialty pharmaceutical company committed to improving the lives of patients. Kyowa Kirin Inc. the U.S. operating entity is expanding its North American footprint by building its first U.S. manufacturing facility in Sanford North Carolina (Sanford) a greenfiel

Kyowa Kirin is a global specialty pharmaceutical company committed to improving the lives of patients. Kyowa Kirin Inc. the U.S. operating entity is expanding its North American footprint by building its first U.S. manufacturing facility in Sanford North Carolina (Sanford) a greenfiel

Kyowa Kirin is a global specialty pharmaceutical company committed to improving the lives of patients. Kyowa Kirin Inc. the U.S. operating entity is expanding its North American footprint by building its first U.S. manufacturing facility in Sanford North Carolina (Sanford) a greenfiel

Kyowa Kirin is a global specialty pharmaceutical company committed to improving the lives of patients. Kyowa Kirin Inc. the U.S. operating entity is expanding its North American footprint by building its first U.S. manufacturing facility in Sanford North Carolina (Sanford) a greenfiel

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company ou

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company ou

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company ou

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company ou